SCHEMBL30834261

SCHEMBL30834261

CCCCOC(=O)N1CCC=C(c2ccccc2Br)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 1/20 0.40
BCHE P06276 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
TSHR P16473 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.37
ALDH1A1 P00352 2/20 0.37
HRH2 P25021 2/20 0.37
HRH1 P35367 2/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30834251 0.80 MAPT (0.45) LMNAKMT2AALDH1A1KDM4EGAA
SCHEMBL30643716 0.77 HRH2 (0.47) LMNASMN1; SMN2POLBL3MBTL1PTGDR2
SCHEMBL31358402 0.75 HTR2A (0.41) LMNASMN1; SMN2L3MBTL1TDP1TSHR
SCHEMBL31357912 0.74 PTGDR2 (0.41) LMNASMN1; SMN2POLBPTGDR2HRH2
SCHEMBL27563812 0.73 LMNA (0.48) LMNASMN1; SMN2POLBBCHEKMT2A
SCHEMBL9627031 0.72 SMN1; SMN2 (0.50) LMNASMN1; SMN2POLBBCHETDP1
SCHEMBL7740552 0.72 SMN1; SMN2 (0.47) LMNASMN1; SMN2POLBBCHEL3MBTL1
SCHEMBL31341987 0.71 P2RY12 (0.34) LMNASMN1; SMN2POLBHRH2HRH1
SCHEMBL30058722 0.71 POLB (0.39) LMNASMN1; SMN2POLBMEN1KMT2A
SCHEMBL16299538 0.71 ALDH1A1 (0.43) LMNASMN1; SMN2POLBL3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024073502-A1 HETEROCYCLIC COMPOUNDS AS E3 LIGASE INHIBITORS ACCUTAR BIOTECHNOLOGY INC. (US) 2024-04-04 WO disclosed